RecruitingNot ApplicableNCT07080788

Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain

Can Smoking Cessation Improve Physiological Markers of Chronic Pain Risk in Native American Smokers?: A Pilot Feasibility Study


Sponsor

University of Oklahoma

Enrollment

150 participants

Start Date

Sep 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this pilot study is to assess whether 4-weeks of verified smoking abstinence following financial incentive treatment for smoking cessation improves physiological markers of chronic pain risk in adult Native American smokers. The main aims to answer are: 1. Determine study feasibility. 2. Obtain effect sizes for changes in pain amplification and pain inhibition in abstinent vs non-abstinent Native Americans. 3. Obtain effect sizes for variables in the conceptual model of the Native American smoking-pain relationship.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Self-identify as Native American/American Indian
  • Currently daily smoker
  • Own a smartphone with a data plan
  • Ability to speak and read English

Exclusion Criteria9

  • \>18 years of age
  • Currently pregnant
  • Self-reported history of heart disease or heart attack
  • Angina, arrhythmias, hypertension, heart disease
  • Current chronic pain
  • Pepper allergy
  • Inability to speak English
  • Current psychosis (assessed by Psychosis Screening Questionnaire)
  • Serious cognitive impairment (assessed by \<20 score on the Montreal Cognitive Assessment \[MoCA\])

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALSmoking Cessation

Investigators will provide financial incentives for biochemically verified abstinence at 4 weeks following treatment. This incentive is consistent with recent research using macro-level financial incentives and incorporates both short-term and long-term incentives to shape behavior.


Locations(1)

University of Oklahoma - Schusterman Center

Tulsa, Oklahoma, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07080788


Related Trials